CryoStor References
Abstracts
2024 | CryoStor® References | Abstracts
Phase 1, Dose Escalation, Nonrandomized, Open-Label, Clinical Trial Evaluating the Safety and Preliminary Efficacy of Allogenic Adipose-Derived Mesenchymal Stem Cells for Recurrent Glioblastoma: A Clinical Trial Protocol
Authors: E.C., A., D.W., A., J.P., Zubair, Middlebrooks, Al-Kharboosh, Chaichana, A.C., E.H., R., K.L., Trifiletti, Abarbanel, Twohy, Green, J.J., D.M., D.N., E.L., Sherman, Durand, Tzeng, Basil, W.J., N., S.Y., A.N., Szymkiewicz, Quiñones-Hinojosa, Dickson, Ramos-Fresnedo, Almeida
Published: Neurosurgery Practice, 2023;Dec;4:e00062
2023 | CryoStor® References | Abstracts
Automated production of gene-modified chimeric antigen receptor T cells using the Cocoon Platform
Authors: D., N., Bryan, Purpura, A., K., Middleton, K., Smith, T., Leonard, Trainor
Published: Cytotherapy, 2023; 25:1349 - 1360
2022 | CryoStor® References | Abstracts
A Novel Cryopreservation and Biobanking Strategy to Study Lymphoid Tissue Stromal Cells in Lymphoproliferative Disorders
Authors: B.T., G., J.D., B., Gonzalez, Allman, De Martin, and Maillard, M., D., A., I., Stanossek, Fajgenbaum, Lϋetge, Y., D.C., M., Camiolo, Aster, Ferreira, E., J.C., A., Gaudette, Wertheim, Brandstadter, Ludewig
2019 | CryoStor® References | Abstracts
ESGCT 27th Annual Congress In collaboration with SETGyc Barcelona, Spain October 22–25, 2019 Abstracts: Manufacture of an ATMP for ex vivo gene therapy of mucopolysaccharidosis IIIA (MPSIIIA)
Authors: D., R., KF, AJ, Pereira, Jones, Ellison, I., SA, SM, Rivat, Bigger, Armenteros-Monterroso, C, BW, E., Ogden, Booth, Diasakou, W., C., A., León-Rico, Wynn, Buckland, Thrasher
Published: Human Gene Therapy.Nov 2019.A1-A221
2019 | CryoStor® References | Abstracts
Manufacture of an ATMP for ex vivo gene therapy of mucopolysaccharidosis IIIA (MPSIIIA)
Authors: D., R., KF, AJ, Pereira, Jones, Ellison, I., SA, SM, Rivat, Bigger, Armenteros-Monterroso, C., BW, E., Ogden, Booth, Diasakou, W., C., A., León-Rico, Wynn, Buckland, Thrasher
Published: Human Gene Therapy, 2019;30:11, A1-A221
2018 | CryoStor® References | Abstracts
A COMPARISON STUDY OF CURRENT FREEZING MEDIA VERSUS CRYOSTOR10 FOR CRYOPRESERVATION OF QC VIALS
Authors: E., Stasko, K., Paciulan, B., Clark
Published: Cytotherapy
2018 | CryoStor® References | Abstracts
A Comprehensive Review of Umbilical Cord Cryopreservation: Umbilical Cord Tissue Banking Cryopreserved Technology and Standard Operating Procedure
Authors: Tsung (John) Dao, Lee
Published: Transfusion
2017 | CryoStor® References | Abstracts
Banking of Human Pluripotent Stem Cells
Authors: Ntai A, Biunno I
Published: Biopreservation and Biobanking
2017 | CryoStor® References | Abstracts
Development and testing of a stepwise thaw and dilute protocol for cryopreserved umbilical cord blood units.
Authors: Elmoazzen H., Pineault N., Pasha R.
Published: Transfusion
2016 | CryoStor® References | Abstracts
Biopreservation considerations in the evolving field of cellular therapies
Authors: Abazari A
Published: Cryobiology
2016 | CryoStor® References | Abstracts
Influencing Differentiation and Growth of Neural Progenitor Cells With Gene Silencing and Laminin
Authors: Ong W, Hon Chooi W, Yian Chew S, Wyatt M
Published: Univeristy of Pittsburgh, Swanson School of Engineering, Undergraduate Summer Research Abstracts
2016 | CryoStor® References | Abstracts
Transplantation of cryopreserved MSC rescues retinal ganglion cells following I/R injury
Authors: Zhu W, Burand A, Ankrum JA, et al., Gramlich OW
Published: ARVO Journal
2014 | CryoStor® References | Abstracts
C-25: Evaluation of closed system medical device for low volume storage for clinical studies involving regulatory T cells.
Authors: Fazekasova H, Thirkell S, Lowe K, Bushell A, Lombardi G., Fearnot ER
Published: Cryobiology
2013 | CryoStor® References | Abstracts
Analysis of HPC and HSC post-thaw viability, clonogenic capacity, and proliferative potential after cryopreservation in comercially available media
Authors: Lutzko C, Leemhuis T, Almulhem N
Published: Cytotherapy
2013 | CryoStor® References | Abstracts
Phenotypic properties of transmitted founder HIV-1
Authors: Gao F, Li H, Giorgi EE, Barbian HJ, Parrish EH, Zajic L, et al., Parrish NF
Published: The Proceedings of the National Academy of Sciences (PNAS)
2012 | CryoStor® References | Abstracts
Cell-based approaches for the treatment of systemic inflammation.
Authors: Yevzlin AS, Lee K, Westover AJ, Smith PL, Buffington DA, Humes HD., Pino CJ
Published: Nephrology Dialysis Transplantation
2009 | CryoStor® References | Abstracts
Notch-Induced Rat and Human Bone Marrow Stromal Cell Grafts Reduce Ischemic Cell Loss and Ameliorate Behavioral Deficits in Chronic Stroke Animals.
Authors: McGrogan M, Matsukawa N, Bankiewicz K, Hara K, Case C, Maki M, Borlongan CV., Ali MM, Yu SJ, Bae E, Yu G, Xu L, Yasuhara T
Published: Stem Cells and Development
September 2024 | CryoStor® References | Abstracts
Local manufacturing processes contribute to variability in human mesenchymal stromal cell expansion while growth media supplements contribute to variability in gene expression and cell function: a Biomedical Excellence for Safer Transfusion (BEST) collabo
Authors: D.H., M., B.H., Jin, Marks, Schäfer, P., D., R., Reems, Geng, Fontaine, J., H., M.J., Stroncek, Pati, Norris, D., S. for Biomedical Excellence for Safer Transfusion (BEST), P.J., McKenna, Tanashi, Shaz
Published: Cytotherapy, 2024;26; Issue 6:531-539
September 2024 | CryoStor® References | Abstracts
Low molecular weight heparin decreases pro-coagulant activity in clinical MSC products
Authors: S.D., J.B., Cox Jr, Triolo, C.S., F., Gill, B.S., Cardenas, J.C., Olson, Schriner
Published: Cytotherapy: Stromal Cell Therapy, 2024;26, Issue 2:194 - 200